{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:21:04Z","timestamp":1715998864633},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10165-010-0370-y","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T21:48:49Z","timestamp":1288907329000},"page":"184-191","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of combination therapy of anti-TNF-\u03b1 antibody infliximab and methotrexate in refractory entero-Beh\u00e7et\u2019s disease"],"prefix":"10.1093","volume":"21","author":[{"given":"Shigeru","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuyo","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hanami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"370_CR1","first-page":"1152","volume":"105","author":"H Behcet","year":"1937","unstructured":"Behcet H. Uber rezidivierende aphthose durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152\u20137.","journal-title":"Dermatol Wochenschr"},{"key":"370_CR2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease. N Engl J Med. 1999;341:1284\u201391.","journal-title":"N Engl J Med"},{"key":"370_CR3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.1997.3611265.x","volume":"108","author":"S Kaneko","year":"1997","unstructured":"Kaneko S, Suzuki N, Yamashita N, et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet\u2019s disease (BD) in Japan. Clin Exp Immunol. 1997;108:204\u201312.","journal-title":"Clin Exp Immunol"},{"key":"370_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","volume":"107","author":"N Yamashita","year":"1997","unstructured":"Yamashita N, Kaneoka H, Kaneko S, et al. Role of \u03b3\u03b4 T lymphocytes in the development of Behcet\u2019s disease. Clin Exp Immunol. 1997;107:241\u20137.","journal-title":"Clin Exp Immunol"},{"key":"370_CR5","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet\u2019s disease A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544\u20139.","journal-title":"J Rheumatol"},{"key":"370_CR6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","volume":"42","author":"MA Frassanito","year":"1999","unstructured":"Frassanito MA, Dammacco R, Cafforio P, et al. Th1 polarization of the immune response in Behcet\u2019s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42:1967\u201374.","journal-title":"Arthritis Rheum"},{"key":"370_CR7","unstructured":"Kappen JH, Dik WA, Dingjan GM, et al. Cytokines in the colon of a patient with Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2009;11:412."},{"key":"370_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2249.2005.02695.x","volume":"139","author":"Y Imamura","year":"2005","unstructured":"Imamura Y, Kurokawa MS, Yoshikawa H, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet\u2019s disease. Clin Exp Immunol. 2005;139:371\u20138.","journal-title":"Clin Exp Immunol"},{"key":"370_CR9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","volume":"49","author":"SP Travis","year":"2001","unstructured":"Travis SP, Czajkowski M, McGovern DP, et al. Treatment of intestinal Bechet\u2019s syndrome with chimeric tumor necrosis factor alpha antibody. Gut. 2001;49:725\u20138.","journal-title":"Gut."},{"key":"370_CR10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","volume":"120","author":"PV Hassard","year":"2001","unstructured":"Hassard PV, Binder SW, Nelson V, et al. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet\u2019s disease: a case report. Gastroenterology. 2001;120:995\u20139.","journal-title":"Gastroenterology"},{"key":"370_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","volume":"46","author":"MT Kram","year":"2003","unstructured":"Kram MT, May LD. Goodman S and Molinas S: Behcet\u2019s ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of cases. Dis Colon Rectum. 2003;46:118\u201321.","journal-title":"Dis Colon Rectum."},{"key":"370_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3904\/kjim.2007.22.1.24","volume":"22","author":"JH Lee","year":"2007","unstructured":"Lee JH, Kim TN, Choi ST, et al. Remission of intestinal Beh\u00e7et\u2019s disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med. 2007;22:24\u20137.","journal-title":"Korean J Intern Med"},{"key":"370_CR13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10350-006-0813-x","volume":"50","author":"JS Byeon","year":"2007","unstructured":"Byeon JS, Choi EK, Heo NY, et al. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Beh\u00e7et\u2019s disease: report of a case. Dis Colon Rectum. 2007;50:672\u20136.","journal-title":"Dis Colon Rectum."},{"key":"370_CR14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10067-006-0410-3","volume":"26","author":"JH Ju","year":"2007","unstructured":"Ju JH, Kwok SK, Seo SH, et al. Successful treatment of life-threatening intestinal ulcer in Beh\u00e7et\u2019s disease with infliximab: rapid healing of Beh\u00e7et\u2019s ulcer with infliximab. Clin Rheumatol. 2007;26:1383\u20135.","journal-title":"Clin Rheumatol"},{"key":"370_CR15","unstructured":"International Study Group for Behcet\u2019s Disease. Criteria for diagnosis of Behcet\u2019s disease. Lancet 1990;335:1078\u20131080."},{"key":"370_CR16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/10428190400027829","volume":"46","author":"R Stasi","year":"2005","unstructured":"Stasi R, Amadori S, et al. Newland AC infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes. Leuk Lymphoma. 2005;46:509\u201316.","journal-title":"Leuk Lymphoma."},{"key":"370_CR17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti-TNF therapy in the management of Behcet\u2019s disease\u2013review and basis for recommendations. Rheumatology (Oxford). 2007;46:736\u201341.","journal-title":"Rheumatology (Oxford)."},{"key":"370_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","volume":"38","author":"M Takeno","year":"1995","unstructured":"Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Beh\u00e7et\u2019s disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38:426\u201333.","journal-title":"Arthritis Rheum"},{"key":"370_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","volume":"14","author":"T Lehner","year":"1997","unstructured":"Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et\u2019s disease. Int Rev Immunol. 1997;14:21.","journal-title":"Int Rev Immunol"},{"key":"370_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00063030-200115010-00003","volume":"15","author":"AI Russell","year":"2001","unstructured":"Russell AI, Lawson WA, Haskard DO. Potential new therapeutic options in Beh\u00e7et\u2019s syndrome. BioDrugs. 2001;15:25\u201335.","journal-title":"BioDrugs."},{"key":"370_CR21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","volume":"41","author":"P Bartolucci","year":"2002","unstructured":"Bartolucci P, Ramanoelina J, Cohen P, et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology. 2002;41:1126\u201332.","journal-title":"Rheumatology"},{"key":"370_CR22","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","volume":"50","author":"GS Hoffman","year":"2004","unstructured":"Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296\u2013304.","journal-title":"Arthritis Rheum"},{"key":"370_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1078\/0171-2985-00197","volume":"206","author":"O Arbach","year":"2002","unstructured":"Arbach O, Gross WL, Gause A. Treatment of refractory Churg\u2013Strauss-Syndrome (CSS) by TNF-alpha blockade. Immunobiology. 2002;206:496\u2013501.","journal-title":"Immunobiology."},{"key":"370_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00063030-200216020-00005","volume":"16","author":"GA Keating","year":"2002","unstructured":"Keating GA, Perry CM, et al. Infliximab an update review of its use in Crohns disease and rheumatoid arthritis. BioDrugs. 2002;16:111\u201348.","journal-title":"BioDrugs."},{"key":"370_CR25","first-page":"472","volume":"30","author":"SD Cha","year":"1997","unstructured":"Cha SD, Llm YS, Kim JW, et al. Response to medical therapy, course and recurrence of colonic lesions in Behcet\u2019s colitis. Korean J Gastroenterol. 1997;30:472\u201380.","journal-title":"Korean J Gastroenterol."},{"key":"370_CR26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02604297","volume":"24","author":"Y Kasahara","year":"1981","unstructured":"Kasahara Y, Tanaka S, Nishino M, et al. Intestinal involvement in Beh\u00e7et\u2019s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24:103\u20136.","journal-title":"Dis Colon Rectum."},{"key":"370_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","volume":"40","author":"LP Robertson","year":"2001","unstructured":"Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behcet\u2019s syndrome with infliximab. Rheumatology (Oxford). 2001;40:473\u20134.","journal-title":"Rheumatology (Oxford)."},{"key":"370_CR28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","volume":"60","author":"PH Goossens","year":"2001","unstructured":"Goossens PH, Verburg RJ, Breedveld FC. Remission of Behcet\u2019s syndrome with tumor necrosis factor alpha blocking therapy. Ann Rheum Dis. 2001;60:637.","journal-title":"Ann Rheum Dis"},{"key":"370_CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Behcet\u2019s disease. Lancet. 2001;358:295\u20136.","journal-title":"Lancet"},{"key":"370_CR30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.61.6.560","volume":"61","author":"G Triolo","year":"2002","unstructured":"Triolo G, Vadala M, Accardo-Palumbo A, et al. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet\u2019s disease. Ann Rheum Dis. 2002;61:560\u20131.","journal-title":"Ann Rheum Dis"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-010-0370-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:23Z","timestamp":1646843123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-010-0370-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s10165-010-0370-y","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]}}}